About
Efrain Talamantes, MD, MS, MSHPM, is Chief Operating Officer (COO) and Designated Institutional Officer (DIO) at AltaMed Health Services in Los Angeles. He is a former Fellow in the NIH-funded Ruth L. Kirschstein National Research Service Award (NRSA) program and a former Scholar in the Robert Wood Johnson Foundation (RWJF) Clinical Scholars Program in the Department of Medicine, David Geffen School of Medicine at UCLA. He is a bilingual (Spanish-English) researcher is interested in conducting research that focuses on kidney transplant disparities in aging minority populations. Dr. Talamantes received a Doctorate of Medicine from the David Geffen School of Medicine at UCLA, a Master of Science in Health Policy and Management from the UCLA Fielding School of Public Health, and a Master of Business Administration from Emory University Goizueta School of Business, Atlanta, GA.
Cohort
2014-15
Project
- “The impact of age, race and ethnicity on kidney transplant mortality.” Dr. Talamantes’ RCMAR/CHIME- and UCLA CTSI-funded project seeks to determine post-transplant mortality by race/ethnicity for older recipients of kidney transplants, while exploring the impact of potentially modifiable factors on survival.